A systematic review of nebulizer use highlighted a few different potential mechanisms for fugitive emissions. Differences in nebulizer design had an impact in the amount and type of fugitive emissions emitted.
Through the choice of an appropriate nebulizer, the natural risk can be greatly reduced, and through selection of appropriate mitigation strategies, the risk can be almost eliminated.
Various improvements have been made to the basic jet nebulizer design with the intent of delivering more medication to the distal airways while still providing aerosol within the respirable range of 3 – 5 μm.
Depending on the pMDI/spacer system chosen the delivery of medication can vary significantly and as a result will have implications on the potential carbon footprint.
In this case, the use of the AeroChamber Plus* Flow-Vu* VHC could potentially reduce the carbon footprint by three fold compared to the alternative spacers.
By maximizing the amount of each puff reaching the lungs the patient is likely to be able to get relief sooner and reduce the amount of puffs needed.
Have you ever struggled with chest congestion or a buildup of mucus in your chest? If so, you're not alone. Many people experience these uncomfortable symptoms, which can be caused by a variety of factors such as the common cold, allergies, asthma or COPD. The article below explores the role of mucus in chest congestion and discuss some ways to clear your airways.
The FRI deposition profiles highlighted significant differences between the VHCs on test, with intrathoracic delivery for the AeroChamber Plus* Flow-Vu* VHC system being almost double that of the other two VHC systems and being similar to the MDI alone with perfect coordination
Depending on the pMDI/spacer system chosen the delivery of medication can vary significantly and as a result will have implications on the potential carbon footprint.
In this case, the use of the AeroChamber Plus* Flow-Vu* VHC could potentially reduce the carbon footprint by three fold compared to the alternative spacers.
By maximizing the amount of each puff reaching the lungs the patient is likely to be able to get relief sooner and reduce the amount of puffs needed.
Have you ever struggled with chest congestion or a buildup of mucus in your chest? If so, you're not alone. Many people experience these uncomfortable symptoms, which can be caused by a variety of factors such as the common cold, allergies, asthma or COPD. The article below explores the role of mucus in chest congestion and discuss some ways to clear your airways.
This article describes the generative, patient-centered, design process used in the development of a prototype VHC intended primarily for use ‘on the go’ by adults with persistent asthma or newly diagnosed COPD.
A systematic review of nebulizer use highlighted a few different potential mechanisms for fugitive emissions. Differences in nebulizer design had an impact in the amount and type of fugitive emissions emitted.
Through the choice of an appropriate nebulizer, the natural risk can be greatly reduced, and through selection of appropriate mitigation strategies, the risk can be almost eliminated.
As the seasons change and the weather gets warmer, people with respiratory conditions such as asthma and chronic obstructive pulmonary disease (COPD) may face new challenges in managing their symptoms. Springtime can bring increased pollen and air pollution levels, which can trigger flare-ups and exacerbations in people with these conditions. However, with some proactive steps, it is possible to manage asthma and COPD effectively during the spring.
Medication delivery can vary significantly depending on the pMDI/spacer system which will have implications on the carbon footprint. In this case, the use of the AeroChamber Plus* Flow-Vu* spacer could potentially reduce the carbon footprint by up to five-fold compared to other spacers.
Rejoignez Jocelyn Vachon, inhalothérapeute, pour en savoir plus sur la thérapie de dégagement des voies respiratoires, un traitement recommandé pour la MPOC, pour aider à la gestion de l'excès de mucus.
AU COURS DE CETTE SESSION, NOUS ALLONS :
✓ Identifiez le rôle du mucus dans les voies respiratoires et explorez la relation entre l'excès de mucus et la MPOC
✓ Découvrez une approche sans médicament de la prise en charge de la MPOC grâce à l'utilisation du dispositif de PEPO Aerobika*
✓ Apprenez à utiliser et à entretenir facilement le dispositif Aerobika*
✓ Examinez l’efficacité du dis
Nous vous invitons à participer à la plus récente séance « Demandez à l’expert » avec Linda Perron, une inhalothérapeute spécialisée en MPOC au Québec. Elle fournira des conseils sur la meilleure façon de prendre en charge la MPOC, sur l’importance du dégagement du mucus et des médicaments par inhalation, ainsi que sur l’impact que la COVID-19 peut avoir sur la MPOC.
Durant le webinaire, on répondra à des questions comme les suivantes :
Asthma impacts different people in different ways. Most people are able to control their asthma with regular use of their controller medication and using their reliever medication when necessary. However, for many it can be difficult to recognize when their asthma is not controlled. When asthma is well-controlled, you will experience little to no asthma symptoms.
Asthma impacts different people in different ways. Most people are able to control their asthma with regular use of their controller medication and using their reliever medication when necessary. However, for many it can be difficult to recognize when their asthma is not controlled. When asthma is well-controlled, you will experience little to no asthma symptoms.
